Article Details

BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate | Financial Post

Retrieved on: 2022-12-23 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate | Financial Post. View article details on HISWAI: https://financialpost.com/pmn/business-pmn/biontech-initiates-clinical-trial-of-mrna-based-malaria-vaccine-candidate

Excerpt

BERLIN — BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, ...

Article found on: financialpost.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up